Diagnostic algorithm for subcentimeter hepatocellular carcinoma using alpha-fetoprotein and imaging features on gadoxetic acid–enhanced MRI
Objective To investigate the role of serum alpha-fetoprotein (AFP) in diagnosing subcentimeter hepatocellular carcinoma (HCC) on gadoxetic acid–enhanced MRI (EOB-MRI). Methods This study retrospectively enrolled treatment-naïve patients with chronic hepatitis B who had a solitary subcentimeter obser...
Saved in:
| Published in: | European radiology Vol. 34; no. 4; pp. 2271 - 2282 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.04.2024
Springer Nature B.V |
| Subjects: | |
| ISSN: | 1432-1084, 0938-7994, 1432-1084 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Objective
To investigate the role of serum alpha-fetoprotein (AFP) in diagnosing subcentimeter hepatocellular carcinoma (HCC) on gadoxetic acid–enhanced MRI (EOB-MRI).
Methods
This study retrospectively enrolled treatment-naïve patients with chronic hepatitis B who had a solitary subcentimeter observation on EOB-MRI from January 2017 to March 2023. Final diagnosis was confirmed by pathology for HCC and pathology or follow-up for benign controls. The AFP cutoff value for HCC was determined using Youden’s index. Diagnostic criteria were developed according to significant findings in logistic regression analyses based on AFP and imaging features. The diagnostic performance of possible criteria was compared to the diagnostic hallmarks of HCC (arterial-phase hyperintensity and portal-phase hypointensity).
Results
A total of 305 patients (mean age, 51.5 ± 10.7 years; 153 men) were divided into derivation and temporal validation cohorts. Four findings, namely AFP >13.7 ng/mL, arterial-phase hyperintensity, portal-phase hypointensity, and transitional-phase hypointensity, were predictors of HCC. A new criterion (at least three of the four findings) showed higher sensitivity than the diagnostic hallmarks (derivation cohort, 71.6% vs. 52.3%,
p
< 0.001; validation cohort, 75.0% vs. 47.5%,
p
= 0.003) without decreasing specificity (derivation cohort, 92.5% vs. 92.5%,
p
> 0.999; validation cohort, 92.0% vs. 92.0%,
p
> 0.999). Another criterion (all four findings) achieved a slightly higher specificity than the diagnostic hallmark (derivation cohort, 99.1% vs. 92.5%,
p
= 0.023; validation cohort, 100.0% vs. 92.0%,
p
= 0.134). Subgroup analysis for hepatobiliary hypointense observations yielded similar results.
Conclusion
Including AFP in the diagnostic algorithm may improve the diagnostic performance for subcentimeter HCC.
Clinical relevance statement
Combining imaging features on gadoxetic acid–enhanced MRI with alpha-fetoprotein may enhance the diagnostic performance for subcentimeter HCC in treatment-naïve patients with chronic hepatitis B.
Key Points
• The traditional diagnostic hallmark of HCC (arterial-phase hyperintensity and portal-phase hypointensity) shows modest diagnostic performance for subcentimeter HCC on EOB-MRI.
• Serum alpha-fetoprotein > 13.7 ng/mL, arterial-phase hyperintensity, portal-phase hypointensity, and transitional-phase hypointensity were independent predictors for subcentimeter HCC.
• A criterion of at least three of the four above findings achieved a higher sensitivity without decreasing specificity.
Graphical Abstract |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ISSN: | 1432-1084 0938-7994 1432-1084 |
| DOI: | 10.1007/s00330-023-10214-0 |